Literature DB >> 22180440

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.

Bree Foley1, Sarah Cooley, Michael R Verneris, Michelle Pitt, Julie Curtsinger, Xianghua Luo, Sandra Lopez-Vergès, Lewis L Lanier, Daniel Weisdorf, Jeffrey S Miller.   

Abstract

During mouse cytomegalovirus (CMV) infection, a population of Ly49H(+) natural killer (NK) cells expands and is responsible for disease clearance through the induction of a "memory NK-cell response." Whether similar events occur in human CMV infection is unknown. In the present study, we characterized the kinetics of the NK-cell response to CMV reactivation in human recipients after hematopoietic cell transplantation. During acute infection, NKG2C(+) NK cells expanded and were potent producers of IFNγ. NKG2C(+) NK cells predominately expressed killer cell immunoglobulin-like receptor, and self-killer cell immunoglobulin-like receptors were required for robust IFNγ production. During the first year after transplantation, CMV reactivation induced a more mature phenotype characterized by an increase in CD56(dim) NK cells. Strikingly, increased frequencies of NKG2C(+) NK cells persisted and continued to increase in recipients who reactivated CMV, whereas these cells remained at low frequency in recipients without CMV reactivation. Persisting NKG2C(+) NK cells lacked NKG2A, expressed CD158b, preferentially acquired CD57, and were potent producers of IFNγ during the first year after transplantation. Recipients who reactivated CMV also expressed higher amounts of IFNγ, T-bet, and IL-15Rα mRNA transcripts. Our findings support the emerging concept that CMV-induced innate memory-cell populations may contribute to malignant disease relapse protection and infectious disease control long after transplantation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22180440      PMCID: PMC3311280          DOI: 10.1182/blood-2011-10-386995

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

1.  Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142.

Authors:  N Jan Chalupny; Annie Rein-Weston; Stephanie Dosch; David Cosman
Journal:  Biochem Biophys Res Commun       Date:  2006-05-24       Impact factor: 3.575

Review 2.  Up on the tightrope: natural killer cell activation and inhibition.

Authors:  Lewis L Lanier
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

3.  Seroprevalence of cytomegalovirus infection in the United States, 1988-1994.

Authors:  Stephanie A S Staras; Sheila C Dollard; Kay W Radford; W Dana Flanders; Robert F Pass; Michael J Cannon
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

4.  Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children.

Authors:  Adriana Monsiváis-Urenda; Daniel Noyola-Cherpitel; Alba Hernández-Salinas; Christian García-Sepúlveda; Neus Romo; Lourdes Baranda; Miguel López-Botet; Roberto González-Amaro
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

5.  Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation.

Authors:  Jill C Beck; John E Wagner; Todd E DeFor; Claudio G Brunstein; Mark R Schleiss; Jo-Anne Young; Daniel H Weisdorf; Sarah Cooley; Jeffrey S Miller; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-26       Impact factor: 5.742

6.  A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature.

Authors:  Sarah Cooley; Feng Xiao; Michelle Pitt; Michelle Gleason; Valarie McCullar; Tracy L Bergemann; Karina L McQueen; Lisbeth A Guethlein; Peter Parham; Jeffrey S Miller
Journal:  Blood       Date:  2007-03-28       Impact factor: 22.113

Review 7.  Immunobiology of human cytomegalovirus: from bench to bedside.

Authors:  Tania Crough; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

Review 8.  Trans-presentation: a novel mechanism regulating IL-15 delivery and responses.

Authors:  Spencer W Stonier; Kimberly S Schluns
Journal:  Immunol Lett       Date:  2009-10-07       Impact factor: 3.685

9.  Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.

Authors:  Enrico Brunetta; Manuela Fogli; Stefania Varchetta; Luisa Bozzo; Kelly L Hudspeth; Emanuela Marcenaro; Alessandro Moretta; Domenico Mavilio
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

10.  Adaptive immune features of natural killer cells.

Authors:  Joseph C Sun; Joshua N Beilke; Lewis L Lanier
Journal:  Nature       Date:  2009-01-11       Impact factor: 49.962

View more
  285 in total

Review 1.  Harnessing adaptive natural killer cells in cancer immunotherapy.

Authors:  Lisa L Liu; Aline Pfefferle; Vincent Oei Yi Sheng; Andreas T Björklund; Vivien Béziat; Jodie P Goodridge; Karl-Johan Malmberg
Journal:  Mol Oncol       Date:  2015-10-20       Impact factor: 6.603

Review 2.  Natural killer cell memory in infection, inflammation and cancer.

Authors:  Adelheid Cerwenka; Lewis L Lanier
Journal:  Nat Rev Immunol       Date:  2016-01-25       Impact factor: 53.106

3.  Activating Receptors for Self-MHC Class I Enhance Effector Functions and Memory Differentiation of NK Cells during Mouse Cytomegalovirus Infection.

Authors:  Tsukasa Nabekura; Lewis L Lanier
Journal:  Immunity       Date:  2016-07-19       Impact factor: 31.745

Review 4.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

Review 5.  Evidence for natural killer cell memory.

Authors:  Assaf Marcus; David H Raulet
Journal:  Curr Biol       Date:  2013-09-09       Impact factor: 10.834

Review 6.  Memory responses of natural killer cells.

Authors:  Clair D Geary; Joseph C Sun
Journal:  Semin Immunol       Date:  2017-08-30       Impact factor: 11.130

7.  Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect.

Authors:  Armin Rashidi; Maryam Ebadi; Bassil Said; Qing Cao; Ryan Shanley; Julie Curtsinger; Nelli Bejanyan; Erica D Warlick; Jaime S Green; Claudio G Brunstein; Jeffrey S Miller; Daniel J Weisdorf
Journal:  Am J Hematol       Date:  2018-05-14       Impact factor: 10.047

8.  NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs.

Authors:  Vivien Béziat; Lisa L Liu; Jenny-Ann Malmberg; Martin A Ivarsson; Ebba Sohlberg; Andreas T Björklund; Christelle Retière; Eva Sverremark-Ekström; James Traherne; Per Ljungman; Marie Schaffer; David A Price; John Trowsdale; Jakob Michaëlsson; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Blood       Date:  2013-01-16       Impact factor: 22.113

9.  Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells.

Authors:  Jeffrey W Leong; Julie M Chase; Rizwan Romee; Stephanie E Schneider; Ryan P Sullivan; Megan A Cooper; Todd A Fehniger
Journal:  Biol Blood Marrow Transplant       Date:  2014-01-13       Impact factor: 5.742

Review 10.  Natural killer cells: walking three paths down memory lane.

Authors:  Gundula Min-Oo; Yosuke Kamimura; Deborah W Hendricks; Tsukasa Nabekura; Lewis L Lanier
Journal:  Trends Immunol       Date:  2013-03-14       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.